Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.
about
Why should primary care physicians know about breast cancer genetics?Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.When research seems like clinical care: a qualitative study of the communication of individual cancer genetic research resultsEthical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?Personal characteristics of older primary care patients who provide a buccal swab for apolipoprotein E testing and banking of genetic material: the spectrum studyGenetic testing and counseling for hereditary forms of colorectal cancer.Breast cancer genetics and managed care. The Kaiser Permanente experience.Genetic counseling in primary care. What questions are patients likely to ask, and how should they be answered?Genetic counseling and clinical cancer genetics services.Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions.Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.Cancer genetic susceptibility testing: ethical and policy implications for future research and clinical practice. Cancer Genetic Studies Consortium, National Institutes of Health.Genetic exceptionalism vs. paradigm shift: lessons from HIV.Missense mutations in disease genes: a Bayesian approach to evaluate causality.Research issues in genetic testing of adolescents for obesity.The translational potential of research on the ethical, legal, and social implications of genomicsHigh frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjectsCorrected Feedback: A Procedure to Enhance Recall of Informed Consent to Research among Substance Abusing OffendersTailoring communication in consultations with women from high risk breast cancer families.Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibilityPerceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.Genetic risk: the new frontier for the duty to warn.Education about genetic testing for breast cancer susceptibility: patient preferences for a computer program or genetic counselor.Genetic testing and its implications: human genetics researchers grapple with ethical issues.American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility.The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Inherited Polyposis Syndromes.The Role of Health Education and Behavior in Public Health Genetics
P2860
Q28383592-67408351-ABE9-4758-8B23-BBC0CAECFC10Q30922016-A1999013-C21A-4569-8C89-263374725E5CQ33320883-CFBFCD45-EC74-4292-B957-C8B4E22FE46BQ33517601-A9E50650-E9A4-44E3-925F-DD0C1F83B501Q33583878-28265898-C664-4813-97D7-8E3A03F3077AQ33814001-904413AB-6D39-4D5D-895F-03428BFD819BQ33814012-5ED92D64-91EB-41D9-A3F7-EDCA63FFD724Q33869757-5796BEE0-17BC-4DF0-BCE1-1287D6599F5AQ33915613-3A7012DB-9A2E-498A-ADDC-EFE88A9A4F91Q33947420-72D9CBD8-699A-4194-942D-994D48BC645BQ34049921-6827E8D6-1D0E-4BAA-8399-F11B20983A23Q34077646-454B0801-18DB-4FC8-957E-2A4F194B24E2Q34087032-8FE6D36D-7705-45DD-B7F8-006F3EEC1946Q34385706-2A0A1896-B3E9-44A7-AFF7-2A912B516B7EQ34451971-A0106601-7061-4258-9B2C-3697BC290B77Q34744623-D7901093-2D8D-47D9-806C-86E786F62071Q35432260-D65D39D9-C318-493E-81D7-7DF22E1950F0Q35540758-157A9FCE-4615-4BA4-8773-A935767E874FQ36646091-42A96BAA-83AD-4B82-87C5-BCF4DA6A955DQ36790121-1CDE34C6-2EE9-479A-9F9C-3CDE6F810807Q36849670-F1912DA7-E440-40B2-A0E2-FBBF3742B514Q37172220-E236DB36-986E-402A-91B4-5FD8B4294A8EQ39429341-B206C092-9B3F-424B-BEBA-172AA014DA99Q40698237-A7704FB5-09A6-4593-BB2B-F951812EA842Q42659899-76A9DA8A-AF36-45B3-8C9B-C2405B351397Q48118061-3DBEA97A-97B3-4887-8057-B601B6225765Q51651054-306DC7C0-2D8C-46E2-97D9-91E7929D309AQ53473705-83AC5DC1-BDEC-441C-A3AA-67BE0CB7B0B2Q53991946-32A6E1DB-FE97-4D3B-B610-C91FA24CB0A7Q57572370-95906145-1D59-4544-A73E-21135106ADE3
P2860
Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Genetic testing for susceptibi ...... d content of informed consent.
@en
type
label
Genetic testing for susceptibi ...... d content of informed consent.
@en
prefLabel
Genetic testing for susceptibi ...... d content of informed consent.
@en
P2093
P1476
Genetic testing for susceptibi ...... d content of informed consent.
@en
P2093
B B Biesecker
J R Botkin
K Schneider
P304
P356
10.1001/JAMA.1997.03540420063031
P407
P577
1997-05-01T00:00:00Z